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Abstract  
RNA is involved in a wide-range of important molecular processes in the cell, 
serving diverse functions: regulatory, enzymatic, and structural. Together with its ease 
and predictability of design, this lends it to become a useful handle for biological 
engineers with which to control the cellular machinery. By modifying the many RNA 
links in cellular processes, it is possible to re-program cells towards specific design 
goals. We propose that RNA can be viewed as a molecular programming language that, 
together with protein-based execution platforms, can be used to re-write wide ranging 
aspects of cellular function. In this review, we catalogue developments in the use of 
RNA parts, methods, and associated computational models that have contributed to the 
programmability of biology. We discuss how RNA part repertoires have been combined 
to build complex genetic circuits, and review recent applications of RNA-based parts 
and circuitry. We explore the future potential of RNA engineering and posit that RNA 
programmability is an important resource for firmly establishing an era of rationally 
designed synthetic biology. 
Introduction  
Many diverse roles of RNA in organisms from all kingdoms and lifestyles have 
been uncovered in the last few decades1–6. Consequently, the understanding of RNA 
has transformed from that of primarily an informational molecule to that of one with 
diverse functions: regulatory, enzymatic, and structural7–12. RNA’s involvement in all 
major molecular processes of the cell– including replication, transcription, and 
translation– allows it to control various aspects of genetic information processing and 
function. This, in turn, enables synthetic biologists and biotechnologists to use RNA as 
a tool for reprogramming cellular machinery towards a range of metabolic, diagnostic, 
therapeutic and environmental applications13–16.  
Central to our ability of being able to design RNA tools for biological 
engineering is the fact that intra- and inter-molecular RNA interactions, as well as 
DNA:RNA interactions, follow simple base-pairing rules that can be used to 
computationally predict cis- and trans- secondary structures for a given sequence using 
free-energy minimization algorithms17–19. Conversely, it is also possible to design by 
inverse folding RNA sequences that meet specific structural constraints20–22. The 
available set of computational methods has successfully bridged the gap between 
sequence and RNA secondary structure, although its de novo tertiary structure 
prediction still remains a challenge23,24. A range of RNA molecules with defined 
biomolecular function, such as transcription termination or catalytic cleavage, are now 
included in libraries of standard biological parts fundamental to synthetic biology25. 
Fortunately, many RNA-based regulatory functions of these parts depend on secondary 
structural interactions, or can be abstracted as such, placing their manipulation firmly 
within our reach. We can introduce specific interactions or eliminate undesirable ones, 
thereby achieving modularity and orthogonality of RNA parts, or creating allosteric 
regions within a given part26–31. RNA predictive power is in stark contrast to de novo 
prediction of protein structure, much less protein:protein interactions or protein:nucleic 
acid interactions, computational solutions for which remain elusive or highly resource 
intensive32–35.  
The programmability of RNA has led to the development of a large repertoire 
of genetic parts, natural and synthetic, that can control wide-ranging functions within 
the cell27,31,36–38. In addition, a number of advanced computational tools have been 
constructed that predict and design the functionality of these parts based on higher-
order mathematical models incorporating RNA interaction energies22,39–43. In this 
review, we start with conducting an examination of the various RNA parts, methods 
and computational tools available for use in synthetic biology. We elucidate their 
design principles, and consider their input-output potential for interfacing with each 
other in multi-component circuitry for onward information processing and signal 
conversion. Next, we look at examples of successful circuit design using one or more 
RNA part types together. Finally, we present a range of applications facilitated by RNA 
parts and circuits, focusing on those that exploit the “programmable” features of RNA, 
and expand on the challenges and potential for the future.  
RNA Parts and Tools 
Large libraries of RNA parts affecting almost every step of biological control 
have become available in the last few years of synthetic biology. In addition to the 
amenability of programming, RNA parts also offer other advantages over protein 
effectors of biological function. Due to their higher turnover rates44–46, RNAs offer 
faster regulation kinetics compared to proteins47,48. Although the metabolic burden of 
maintaining plasmids that code for synthetic parts would be similar for RNAs and 
proteins49,50, protein overexpression is often accompanied by toxicity effects due to the 
“protein cost” that depletes the cell of ribosomal resource51–53. Consequently, despite 
comparable output, genetic designs with higher mRNA transcription rates have better 
efficiency than those with higher protein translation rates since the latter divert more 
ribosomal resource54. RNA production being less costly allows the advantage of 
achieving higher abundance of effector RNAs relative to the target, in turn, reducing 
chances of retroactivity55. Here we discuss the key RNA parts and associated tools that 
have advanced RNA circuit programming to a whole new level13,56 (Figure 1). 
	
Figure 1. RNA parts can be used to regulate a wide range of genetic control functions. 
(A) Strength of interaction between the anti-Shine Dalgarno (aSD) sequence and the ribosome 
binding site (RBS) is an important determinant of translation initiation. By modelling these 
interactions, the RBS Calculator model can predict the TIR of mRNA ORFs across multiple 
species40. (B) Ligand-binding aptamers can be placed upstream of a gene of interest to create 
riboswitches, such that binding-induced conformational change alters access of the translation 
machinery to the gene's RBS. Shown below are the ligand-bound secondary structures of six 
aptamers41. (C) By modelling the energetics of RNA:RNA interaction, trans-activating small 
RNA regulators of translation can be designed computationally22. (D) Aptamers can be fused 
with ribozymes to create aptazymes, which can regulate translation of a downstream gene upon 
ligand binding. (E) Small transcription activating RNAs prevent transcription termination by 
disrupting the terminator hairpin loop that would otherwise cause RNAP dislocation38. (F) 
Binding of the dCas9 protein can also block transcription by preventing RNAP translocation 
along the DNA template. 
Ribosome Binding Sites 
Ribosomes are large multi-subunit ribonucleoproteins (RNPs) composed of 
ribosomal proteins and RNAs (rRNAs) that translate protein coding mRNAs. Although 
the tertiary structure of rRNAs forms the bulk of the ribosome57, to the biological 
engineer interested in regulating protein expression, bacterial ribosomes can be 
abstracted to be represented by their anti-Shine Dalgarno (aSD) sequence, the 16S 
rRNA 3’end that interacts with the ribosome binding site (RBS) on the 5’UTR of the 
mRNA to form the translation initiation complex. By manipulating the interaction 
between the aSD and the RBS, the rate of binding of the ribosome to the mRNA, and 
hence the translation initiation rate (TIR) can be altered. This was previously achieved 
by mutating the RBS sequence towards a desired protein expression level58.  
Of late, de novo design of RBS sequences has been made possible by various 
computational tools that can predict the TIR of a given mRNA ORF as well as reverse 
engineer mRNA sequences for ORFs with a specified TIR. Two such tools, the RBS 
Calculator and the UTR Designer (Table 1)42,43,59, have been used successfully in 
multiple bacterial species for tuning protein expression levels across several orders of 
magnitude40,60–63 (Figure 1A). They use similar models to predict the TIR of a given 
mRNA ORF by calculating the energy of interaction between the ribosome and the 
mRNA, incorporating contributions from energies of: (a) rRNA:mRNA binding, (b) 
tRNAfMet:start-codon binding, (c) compensation for non-optimal spacing between the 
SD and the start-codon, and (d) penalty due to 5’UTR structure that affects ribosome-
mRNA interaction. However, the two use different methods to calculate energy penalty 
due to the structured 5’UTR42,43. The RBS Designer tool takes a different approach by 
calculating “translation efficiency” as the probability of binding of a free ribosome to 
the SD sequence on an mRNA64, while EMOPEC uses a position specific weight matrix 
to determine translation rate from a specific SD sequence in E. coli65. 
The above tools also provided evidence that the same RBS sequence can have 
vastly different translation rates (530-fold in one example59) for two different ORF 
sequences, underlining the importance of building good mathematical models and the 
limits of standardized parts libraries as used in synthetic biology25,59. Since these tools 
report TIR on a relative scale specific to a given ORF, the effects of independent 
variables like DNA copy number, transcription rate, codon usage, protein size, protein 
solubility or other factors affecting translation elongation or termination can be ignored. 
However, this also implies that comparing TIR values across different ORFs is unlikely 
to correlate with protein abundance, as was recently found by ribosome profiling66. 
Although much progress has been made in the predictable tuning of protein expression, 
further improvements could include the kinetics of mRNA folding and 
ribosome:mRNA interaction in the initiation model, account for differences in mRNA 
and protein half-lives, and incorporate elongation and termination into a comprehensive 
translation model67,68. 
Riboswitches 
Riboswitches are structured RNA elements usually found in the untranslated 
regions of the mRNA, such as 5’UTRs or the transcriptional terminators, of their 
regulated genes. They consist of a ligand-binding domain, the aptamer, which is 
coupled to an expression platform such that a ligand-induced conformational switch in 
their structure alters access to a translationally relevant part of the mRNA, like a 
prokaryotic RBS or a eukaryotic 5’cap, or the production of an intrinsic transcriptional 
terminator or anti-terminator stem69–71 (Figure 1B). Riboswitches are found in all 
domains of life and can bind to a wide range of ligands including purines, antibiotics, 
vitamins and secondary metabolites72. Natural riboswitches have been engineered to 
recognize alternative natural and unnatural ligands73, while some synthetic 
riboswitches have been designed from ligand-binding aptamers in parts by rational 
design and functional screening74–77. However, despite SELEX-driven identification of 
a number of aptamer molecules de novo design of riboswitches remains considerably 
challenging78,79. A recent computational biophysical model was used to design 62 
translation-regulating riboswitches from six ligand-binding aptamers, achieving up to 
383-fold activation41. Like the RBS Calculator model, the Riboswitch Calculator 
(Table 1) considers the free energy change from a folded mRNA state unbound to the 
ligand and the ribosome to a ligand-bound mRNA in complex with the ribosome, and 
uses it to calculate the activation fold of the riboswitch. The work leading up to the 
thermodynamic model confirms previous observations that riboswitch activation 
requires co-transcriptional kinetic trapping of the mRNA in the ligand-bound state75, 
and uncovers the role of molecular crowding in  riboswitch activation. It also calculates 
the theoretical limits of using a hypothetical ideal riboswitch as a biosensor, predicting 
that based on thermodynamic considerations the best translation riboswitch will only 
activate ~20-fold at nanomolar ligand concentrations. However, these theoretical 
thermodynamic limits could be circumvented by the kinetics of the various steps 
involved in riboswitch activation: (1) mRNA folding, including transcription rate, (2) 
ligand binding, including aptamer preorganization and kinetic proofreading, and (3) 
ribosome binding to the mRNA80–84. 
Translation Riboregulators 
Trans-acting riboregulators are small RNA (sRNA) molecules that, like 
riboswitches, regulate mRNA translation by controlling access of the cell’s ribosomal 
machinery to the mRNA85,86. The most common point of control is translation initiation, 
when the 16S rRNA aSD interacts with the RBS to form the translation initiation 
complex. sRNA-mediated activation is possible in mRNAs where a structured 5’UTR 
occludes the RBS in the OFF state, and only allows ribosomal access upon 
conformational change induced by sRNA binding22,87.  
In addition to the advantage of RNA programmability, sRNA-based regulators 
have faster regulation kinetics than proteins due to their shorter half-lives48. 
Additionally, translation regulators have quicker response times than transcriptional 
ones since all the interacting molecules have already been transcribed88. The 
sRNA:mRNA interaction is initiated at a seed site of sequence complementarity 
between the two molecules and proceeds along the thermodynamic energy gradient. 
The energetics of these interactions and the RNA structural constraints were used to 
build a thermodynamic model of sRNA-mediated translation activation and design 
many synthetic riboregulators of up to 10-fold activation22,89 (Figure 1C). The model 
was also published as an online tool for riboregulator design, the Ribomaker (Table 
1)89.  While the original strategy employed structural constraints to position the RBS in 
a hairpin stem as a way of maintaining the OFF state, later work has employed a 
different strategy in the design of “toehold switches” where the RBS is maintained in 
the unpaired loop of the folded hairpin but translation initiation is prevented by burying 
the translation start site in the paired stem. The latter design has the advantage that the 
folding energies of the hairpin-loop structure and the RBS strength can be tuned 
relatively independently.  
sRNA-mediated translation repression also follows similar rules of 
sRNA:mRNA interaction, except in this case the binding of the sRNA results in the 
occlusion of the RBS. This process of translation repression can either be aided by the 
Hfq RNA chaperone, or operate independently of it90.  Unlike sRNA-mediated 
translation activation that requires a structured 5’UTR in the OFF state, sRNA-
mediated repression is possible to design for almost any mRNA as long as the designed 
repressing sRNA can bind it with sufficient strength to prevent translation initiation or 
elongation15,91. 
Table 1: Computational tools for RNA synthetic biology 
Tool Modes Modes Refs. Model details 
RBS Calculator 
(v1, v1.1, v2) 
(Online) 
Forward Engineering 
(v1.1) 
 
 
 
 
 
Designs ribosome 
binding site with 
specified translation 
initiation rate (TIR) 
 
 
 
 
40,42,59 • Calculates TIR as a function of the 
strength of binding between the 16S 
rRNA 3’end and the mRNA.  
• Version 2 accounts for structured 
standby sites upstream of the Shine 
Dalgarno sequence based on 
biophysical constraints. 
• Most frequently updated model. 
Forward Engineering 
Library (v1.1) 
Designs a degenerate 
library of ribosome 
binding sites with a 
specified range and 
resolution of TIRs 
40 
Reverse Engineering 
(v1, v1.1, v2) 
Predicts TIRs of start 
codons in the input 
mRNA sequence 
40,42,59 
UTR Designer 
(Online) 
Forward Engineering 
 
 
 
 
Designs 5’UTR with 
specified expression 
level 
43 • Calculates protein expression level by 
calculating strength of binding between 
the 16S rRNA 3’end and the mRNA.  
• Accounts for local structure near the 
Shine Dalgarno sequence based on 
ensemble average. 
• Allows codon optimization of the ORF 
to achieve desired expression level. 
Forward Engineering 
Library 
 
Designs a degenerate 
5’UTR with a specified 
range and resolution 
of expression levels 
92 
Reverse Engineering Predicts expression 
level of the input gene 
43 
Riboswitch 
Calculator 
(Online) 
Reverse Engineering Predicts TIR of the 
gene in the riboswitch 
mRNA, in the 
presence and the 
absence of the ligand 
41 • Calculates TIR as a function of the 
strength of binding between the 16S 
rRNA 3’end and the mRNA, accounting 
for different aptamer structures in the 
presence and the absence of the ligand. 
• Also predicts the fold activation at 
varying concentrations of the ligand and 
the mRNA 
Ribomaker 
(Online) 
Forward Engineering Designs sRNA and/ or 
mRNA sequences for 
specified structural 
constraints in the 
resulting heterodimer 
89 • Designs one or more RNA sequences 
based on the biophysics of 
intermolecular interaction 
CasOT 
(Downloadable) 
Search single-gRNA, 
paired-gRNA, and 
target-and-off-target 
Search for target sites 
of a gRNA sequence 
through specified 
genomes 
93 • Uses pattern matching for the sgRNA-
PAM combination to determine target 
and off-target hits 
Ribozymes 
Ribozymes are a class of enzymatic RNA molecules that adopt a specific 
tertiary structure allowing for cleavage of the RNA molecule at a defined locus94. The 
self-cleaving property of these ribozymes has been used in synthetic biology for 
insulation of RNA parts from their surrounding context, or for self-processing of large 
RNAs95,96. With the knowledge of the ribozyme structure, its cleavage may be regulated 
by the insertion of an aptamer whereby the necessary structural confirmation required 
for catalytic activity is met only when the aptamer binds to a small molecule ligand. 
Such ligand-induced ribozymes, called aptazymes, can be designed to regulate gene 
expression and therefore act as molecular sensors of small molecules97–99 (Figure 1D). 
Using similar principles of conformational switching, computational methods have 
been used to calculate secondary structure of the ribozyme molecules to engineer 
ribozymes for ligand-induced release of riboregulators37. These sRNA-releasing 
ribozymes, called “regazymes”, can also be re-programmed to sense specific sRNAs, 
converting them into signal relay molecules. As with riboswitches, induced 
conformational changes in aptazymes are often co-transcriptional, making kinetic RNA 
folding method like Kinefold more useful for their design100,101. 
Transcriptional Regulators 
Rho-independent or intrinsic transcriptional terminators represent one of the 
most well-known example of functional structured RNAs, and are responsible for ~80% 
of all transcription termination events in E. coli102. They consist of a conserved RNA 
hairpin-loop motif, with a ~5-9 nt long stem and 3-5 nt loop, and are followed by a U-
tract of 7-9 nt. While the U-tract causes the RNA polymerase to pause during 
transcription, the formation of the hairpin destabilizes the transcription elongation 
complex resulting in the eventual dislocation of the RNA polymerase from the 
DNA103,104. With the knowledge of the molecular mechanism in action, many synthetic 
terminators have been designed with a wide range of termination efficiencies, often 
surpassing those of natural terminators, or with engineered bidirectional 
functionality105–107. Based on the measured termination efficiencies and an analysis of 
sequence and secondary structural features, linear regression and biophysical models 
have been built to predict termination function of a given terminator sequence106,107. 
Since transcriptional termination requires the slowing down of RNA 
polymerase and the formation of a destabilizing hairpin-loop, different anti-termination 
strategies have also evolved in nature to regulate termination108–110. These have 
subsequently been adapted to design multiple orthogonal parts for regulating 
transcription termination. Inspired by the pT181 attenuator, researchers have designed 
antisense sRNAs that can effectively repress transcription by stabilizing an otherwise 
weak terminator hairpin, resulting in premature termination of mRNA30,111. 
Conversely, small transcription activating RNAs (STARs) have been designed that 
activate transcription by sequestering the 5’proximal arm of the terminator hairpin, 
resulting in onward transcription of the mRNA38,112 (Figure 1E). Both these sRNA-
triggered methods of transcriptional regulation can be used in many combinations for 
genetic circuitry involving RNA-only signal propagation. Furthermore, E. coli’s 
leader-peptide regulatory element from its tna operon has been adapted to activate 
transcription by translation-mediated anti-termination31. Therefore, the synthetic tna-
derived adaptor acts as a signal converter in a genetic circuit, converting a translation 
signal to a transcription signal by closely interfacing the ribosome and the RNA 
polymerase. Viewed from an electronics perspective, this is analogous to a translation 
current expressed as ribosomal flux (RiPS, ribosome per second) being converted to a 
transcription current expressed as polymerase flux (PoPS, polymerase per second) via 
“common signal carriers”– the ribosomes and the RNA polymerases113,114. 
CRISPR/Cas9 
The Cas9 endonuclease is the enzymatic component of the RNP machinery that 
effects a double-strand break at a specific DNA sequence as a part of the antiviral 
immune system of bacteria115. Its specific site of action is defined by the crRNA 
(CRISPR RNA), which forms a complex with the tracrRNA (trans-activating CRISPR 
RNA) to direct the Cas9 to its complementary DNA sequence115,116. The natural dual 
RNA complex has been engineered to a simpler single small guide RNA (sgRNA) that 
contains the region complementary to the target DNA sequence near a recognition motif 
called PAM116,117. The rest of the sgRNA consists of a Cas9-handle that facilitates its 
docking into the Cas9 protein118. The Cas9-sgRNA pair are self-sufficient and do not 
require any other host factors, as evidenced by their standalone application in diverse 
prokaryotic and eukaryotic hosts119–121. By modifying the sequence-specificity region 
of the sgRNA, it is possible to target it to any location in the genome or a plasmid. 
While the catalytically active version of Cas9 has been applied in diverse genome 
engineering applications119,122, the inactive dCas9 has been used or reprogrammed, by 
fusion with other domains, for use as a sequence-specific activator or repressor with 
high specificity123,124 (Figure 1F). The high programmability and specificity of sgRNA 
sequence as well as the availability of mutually orthogonal Cas9 proteins with different 
PAM recognition motifs has facilitated parallel application of the Cas9 technology for 
targeting of multiple DNA loci simultaneously using orthogonal sgRNAs125–127. 
Inducible reconstitution of split-Cas9 protein has allowed greater temporal control over 
its activity128,129. Furthermore, antisense RNA-mediated regulation of sgRNA function, 
and engineering additional RNA motifs onto the sgRNA has made possible the 
recruitment of other effector proteins with diverse functions, expanding the range of 
Cas9-mediated regulatory action130–132. 
RNA Circuits 
With rapid expansion in the number of and types of available RNA parts, building 
higher-order RNA-based genetic circuits is now possible, including some RNA-only 
ones88,111. While the orthogonality of many of these parts has facilitated their 
simultaneous use in genetic circuits27,73,125,133, better understanding of their design rules 
has also allowed construction of many hybrid parts with composite functions37,38,130,134. 
Furthermore, RNA parts are relatively universal and can be easily ported from one 
species to another135. The improved dynamic ranges of RNA parts have also improved 
their ability to interface with other parts, further enhancing their composability. As a 
result, RNA-based circuits have now been successfully used to implement logic gates, 
feedback controls, feed-forward loops, and regulatory cascades37,88,136 (Figure 2). Here 
we discuss some RNA circuit designs to provide better appreciation of the 
achievements and potential of RNA-based circuitry, putting in context the previously 
discussed RNA parts. 
	
Figure 2. RNA parts can be assembled into multi-layered circuitry. (A) Computational 
design of tunable RBS sequences allows construction of a mixed feedback loop of orthogonal 
polymerase (T7RNAP) and repressor (TetR) molecules, enabling gene expression in a host-
promoter independent manner135. (B) Hfq-chaperoned binding between sRNA and mRNA 
results in translation repression of the latter. This has been used for metabolic engineering in 
E. coli to increase tyrosine production15. Genes in red were targeted for sRNA-mediated 
combinatorial repression while those in green were overexpressed on plasmids in fourteen 
strains (* indicates feedback-resistant mutant of the overexpressed gene). (C) Composite parts 
like regazymes (sRNA emitting aptazyme) can be used to build RNA-only circuits, such as the 
3-input AND gate demonstrated here37. (D) Orthogonal sgRNAs, together with the dCas9 
repressor,  have been used to build higher order genetic circuits125. 
Ribosomal circuitry 
While proteins are the specialized reservoirs of the bulk of enzymatic activity 
in the cell, by leveraging the role of RNA in protein expression we can gain greater 
programmable control over their function. As discussed earlier, by engineering 
ribosome:mRNA interactions using translation initiation models, we can tune protein 
expression over a large dynamic range within the cell42,43,59. The RBS Library 
Calculator and the UTR Library Designer, add-on tools to the respective computational 
models, can design a degenerate RBS sequence to span a range of protein expression 
space, further enhances this ability40,92. This methodology has been used to tune the 
knobs of multi-dimensional enzyme expression spaces to determine the optimal 
stoichiometry of individual enzymes that achieve a balanced pathway for neurosporene, 
NADPH, lysine and hydrogen production40,63,92. Total enzyme expression can be 
subsequently increased, while maintaining relative enzyme stoichiometry, to further 
improve production. The ability to engineer multi-dimensional tunable protein 
expression has also been used to create mixed feedback loop transcriptional genetic 
circuits for autonomous regulation of the orthogonal T7 RNA polymerase to cap 
toxicity, allowing conversion from a RiBS signal to a PoPS signal, and facilitating inter-
species portability of genetic parts and pathways135 (Figure 2A).  
The ability to engineer the translation process by manipulating rRNA:mRNA 
interaction has also been pursued from the rRNA end with exciting implications. By 
manipulating the aSD sequence, orthogonal ribosomes with alternative RBS 
specificities have been created137,138. Orthogonal ribosomes open up new avenues for 
biological engineering by helping partition the translation machinery into separate 
mRNA pools, one for native cellular functions and the other for the use of the biological 
engineer, facilitating otherwise difficult to implement design paradigms like synthetic 
amino acid incorporation into peptides or quadruplet-codon decoding ribosomes139–141. 
rRNA engineering has recently led to the development of a single subunit ribosome 
(Ribo-T) that has the potential to further expand RNA control over protein 
regulation142. 
Small RNA circuitry 
As seen earlier, sRNA binding to the mRNA can abolish translation initiation 
or elongation, thereby allowing direct control over protein expression in the cell. Recent 
work has expanded this approach to implement a combinatorial knockdown of multiple 
genes using synthetic sRNAs for metabolic engineering of biosynthetic pathways in 
E. coli. In order to redirect flux through the tyrosine production pathway, four genes 
(csrA, pgi, ppc and tyrR) were targeted for repression in a number of cell lines, 
improving tyrosine production dramatically15 (Figure 2B). In the most productive 
strain, the simultaneous application of sRNAs results in a genetic NOT-AND-NOT gate 
for tyrR and csrA genes. In the same study, repressing six of eight target genomic loci 
by sRNAs led to an increase in cadaverine production by ~55%. sRNA circuits have 
also been built for activating translation of genes with structurally repressed 5’UTRs. 
A combination of these trans-activating riboregulators has been used to build RNA 
circuits that trigger physiological responses like λ-phage lysis, integrate simple 2-input 
or more complex 4-input AND gate logic, and implement transcriptional cascades in 
vitro22,87,133,143. 
In addition to manipulating expression by regulating translation, sRNAs have 
also been used to regulate transcription in synthetic genetic circuitry. The pT181-
inspired sRNA-triggered attenuators have been used to implement RNA-only NOR 
gate logic and a 3-step cascade88,111. Similarly, the previously discussed transcription 
activating STARs have been used to design many orthogonal activating RNAs reaching 
activation folds of up to 94-fold, and the implementation of novel RNA-only AND and 
NIMPLY logic gate organisations38.  
Riboswitch circuitry 
As reviewed recently, simple logic gate circuit functionality already exists in a 
number of naturally occurring riboswitches144. The glmS riboswitch integrates glucose-
6-phosphate and glucosamine-6-phosphate signals, while the add riboswitch integrates 
adenine and temperature signals in an OR gate fashion145,146. Similarly, the metE 
riboswitch responds to S-adenosylmethionine and vitamin B12 in a NOR gate logic147. 
Synthetic riboswitches have also been built using design and selection methodologies 
to process AND and NAND gate logics, or act as band pass filters134,148. More 
generalizable strategies have also been used to implement additional logic gate 
functions like OR and NOR, and signal filters149. 
Riboswitches can also be combined together, or joined with other RNA parts, 
to make composite parts with novel functionalities134. By fusing a ligand-binding 
riboswitch to a ribozyme, researchers have been able to create a larger array of logic 
gate circuits: AND, NOR, and NAND gates149,150. Similarly, researches have created 
an sRNA-emitting ribozyme, called regazyme, that responds to a small molecule or a 
specific sRNA trigger by cleaving to release another sRNA for downstream function. 
The regazyme can also be activated by an sRNA, acting as a signal relay inside cells37. 
The regazymes have been used to build 2- and 3-input AND gate logic circuitry (Figure 
2C).  
CRISPR/Cas9 circuitry 
The CRISPR/Cas9 system uses a small guide RNA (sgRNA) sequence for 
recognition specificity for binding to its DNA target, facilitating the use of orthogonal 
sgRNA sequences for targeting multiple locations in the DNA. Using the catalytically 
dead dCas9 protein, this has enabled the development of genetic circuitry with complex 
logic gate functions like NOT-NOT, NOR, NOR-NOT, NOR (NOT-NOT) where 
dCas9 acts as a programmable repressor in bacteria125 (Figure 2D), repressing a gene 
by blocking the access of RNA polymerase (RNAP) to its promoter. Moderate success 
has also been achieved in turning dCas9 into a transcriptional activator by fusing it to 
the omega subunit of bacterial RNAP123. It may be possible to further improve this 
strategy by using stronger activation domains, or harnessing transcriptional activity 
from an orthogonal RNA polymerase fragment151.  
dCas9 has also been used to build higher-order layered genetic circuits for 
decision-making in eukaryotic cells, including yeast and mammalian152,153. Unlike in 
bacteria, dCas9 binding on its own is quite inefficient for transcriptional repression in 
eukaryotes154,155, where most successful CRISPRi strategies have relied on using one 
or more repressor domains fused to dCas9154–156, or a repressor protein recruited via an 
RNA-binding domain130, to inactivate a promoter at the chromatin level. However, a 
recent report in Drosophila has demonstrated efficient transcriptional knockdown by 
using targets closely flanking the transcription start site157. This strategy should be 
attempted in more eukaryotes as it is likely to be more precise than chromatin 
modifying domains that have wider effect on surrounding genomic loci158. Similar to 
bacteria, dCas9-mediated activation (CRISPRa) in eukaryotes too requires an 
activation domain recruited to the promoter site to modify the local chromatin 
state130,159–161. As an alternative to activation domains, it may also be possible to 
achieve activation of a gene by dCas9-mediated disruption of +1 nucleosome 
positioning that blocks the RNA polymerase from progressing downstream from the 
nucleosome free region162,163. 
Applications 
The versatility of structure and function of RNA devices, along with their 
programmable nature, has permitted their use in a multitude of biological, 
biotechnological and medical applications (Figure 3). Many of these applications use 
parts and circuitry discussed earlier in this review. We consider some of them here, 
focusing on those applications where the programmable aspects of RNA function have 
been harnessed. 
Riboswitch sensors for bio-production 
The ability of riboswitches to control gene expression in response to small 
molecule binding has found them use in bio-production as sensors of desired molecular 
products or of metabolic intermediates. The possibility of identifying novel small-
molecule binding aptamers by in vitro selection78, followed by building artificial 
riboswitches or other aptamer-regulated RNA parts11,37, makes them appealing as 
control circuits during biotechnological production of useful chemicals. Successful 
riboswitch-mediated enrichment of cells able to sense theophylline after mixing with 
non-sensing cells first hinted at the possibility of linking riboswitch based selection to 
directed evolution164. Riboswitches have subsequently been used to differentiate E. coli 
cells producing vitamin B12 from non-producers, to screen libraries of caffeine 
demethylase variants in yeast for higher enzyme activity, and to evolve a chimeric 
aspartate kinase sourced from Bacillus subtilis and Thermus thermophilus for higher 
lysine production165–167. In addition to evolving enzymes individually, riboswitch 
sensors have also been used to simultaneously optimize expression levels of multiple 
enzymes to redirect metabolic flux towards a product of interest in both bacteria168 and 
yeast169.  Similarly, aptazyme riboswitches have been used for enhanced xanthine and 
vitamin B2 production in yeast and Bacillus, respectively170,171 (Figure 3A).  
	
Figure 3. RNA function has been harnessed for a number of biological applications. (A) 
A library of vitamin B2 producing B. subtilis variants was screened using alginate beads as 
nanolitre reactors. E. coli cells, with an engineered riboswitch, were used for sensing and 
reporting B2 in the beads171. (B) Cas9-based repression and activation was used in yeast to 
enable programmable routing of metabolic flux from L-tryptophan to one of four different 
pigments produced in the violacein pathway130. RNA motifs MS2 and PP7 were added to the 
sgRNA to act as bait for the recognition domains fused to VP64 trans-activator to attract it to 
the relevant gene. (C) RNA can be used as scaffold for spatial organization of enzymes. Using 
RNA motifs MS2 and PP7 to recruit enzymes ferredoxin (F) and hydrogenase (H) to RNA 
molecules with 0D, 1D and 2D higher order structures (D0FH, D1FH and D2FH) increases 
hydrogen yield by up to 4-fold, 11-fold and 48-fold, respectively, compared to unscaffolded 
proteins (leftmost bar)172. The RNA-protein monomers and dimers that assemble into larger 
structures are also shown. The grey boxes show simplifications of the RNA-protein dimers that 
organize to form the higher-order structures, together with the polymerization domain tails with 
RNA directionality for pairing. (D) Cas9 nuclease with programmable sequence-specificity has 
been employed with engineered phagemids to selectively kill methicillin resistant S. aureus173. 
The CRISPR array sequence was designed to target both resistance plasmids pUSA01 and 
pUSA02 for curing. 
Small RNA regulators for metabolic engineering 
sRNA regulators of gene expression can be easily directed against natural genes 
as they work through base pairing with their target sequences. As such, they can be 
designed with relatively high throughput, and large scale knockdown of key genes in 
metabolic pathways can be programmed to divert carbon fluxes and increase 
production. This was originally achieved using asRNAs (long antisense RNAs), and 
later improved by the use of PTasRNAs (paired termini asRNA)174,175. As discussed 
previously, synthetic sRNA negative riboregulators have also been used to knockdown 
regulators of metabolic pathways and achieve high titers of tyrosine (2 g/L) and of 
cadaverine (12.6 g/L)15. Since sRNA-mediated gene regulation can function without 
modifying the genome, such RNAs can be used to rapidly engineer microbial cell-
factories across different species of bacteria176. In addition to regulating translation, 
CRISPRi sgRNAs can also be used in a similar way for rapid and multiplexed 
transcriptional repression of flux genes using the dCas9 protein, as was done for the 
polyhydroxyalkanoate pathway in E. coli177. Fusion of the sgRNA with other RNA 
motifs for accessory protein recruitment has permitted activation or repression of genes 
based on the sgRNA input, allowing rerouting of metabolic flux to different pigment 
outputs depending on the RNA program input in yeast130 (Figure 3B). 
RNA scaffolds for biotechnology 
The base pairing properties of RNA allow it to be assembled into different 
shapes in vitro178. These properties have also been used in vivo to create scaffolds on 
which to assemble enzymes for increasing production of various molecules. A 
sequence-programmed RNA scaffold can be used to control the spatial organization of 
hydrogen producing enzymes in E. coli172. The authors fused different RNA binding 
domains (MS2 and PP7) to the two enzymes required for hydrogen production in E. 
coli, to immobilize them to a specific region of the RNA scaffold. By incorporating 
RNA binding domains onto different RNA scaffolds that assembled into 1 or 2 
dimensional structures, they were able to increase hydrogen output by up to 48-fold 
(Figure 3C). This method was expanded to increase pentadecane titers up to 140% and 
succinate up to 88%, allowing the co-localization of up to four enzymes179. 
Molecular diagnostics  
The ability of RNA circuits to detect small molecules and specific RNA 
sequences, as well as the possibility of using the circuits in cell free extracts, has led to 
the exciting development of paper-based “toehold switch” riboregulators, which can be 
freeze-dried on a paper matrix with cell free extract and functionalized after 
rehydration87,133. These sensors can detect specific RNA sequences through binding of 
complementary regions and strand-displacement. Early examples include 
differentiating between two different Ebola virus strains, although the strategy can 
easily be expanded to detect other RNA sequences. The cell-free nature of the system 
makes it cheap, portable, and better suited to a regulatory environment where 
genetically engineered material could not be used in the field.  
Smart therapeutics 
The application of synthetic RNA devices and circuits for medical uses is a 
particularly promising route. RNA based “smart” antimicrobials have been developed 
to kill bacterial cells using readily programmable sequence-specific targeting. Almost 
20 years ago, an sRNA acting as external guide sequence was used to target bacterial 
antibiotic resistance mRNAs for RNase P degradation180. More recently, riboregulators 
and CRISPR/Cas9 nuclease have been delivered into E. coli to either repress antibiotic 
resistance genes and restore sensitivity, or to kill bacteria in a sequence specific 
manner173,181,182 (Figure 3D). These proof of principle examples demonstrate the 
antimicrobial potential of RNA circuits for specific bacterial targeting. In addition, 
more complex responses based on devices that sense small molecules and other RNAs, 
as well as layered circuits that integrate multiple inputs, are also possible in mammalian 
cells. Delivered though specialized vectors183, such circuits can read the cellular state 
and integrate multiple signals like viral RNAs or cancer-associated metabolites to 
produce conditional outputs like apoptotic or immune-stimulatory response184. To 
improve half-lives and reduce immunogenicity of the delivered RNA molecules 
modified bases such as pseudouridine can be substituted into them185, while also 
continuing to assist RNA programmability by improving existing secondary structure 
prediction models to capture the altered biophysics of molecular interaction by such 
bases186. 
Cellular RNA editing 
Group I self-splicing introns can be used to engineer trans-splicing ribozymes 
for directed editing of RNAs using base-pairing programmable “guide sequences”187–
189. These have been used to repair the disease form of mRNAs, in sickle cell ß-globin 
mRNA190,191 and myotonic dystrophy DMPK mRNA192 for example, or target dengue 
virus  conserved RNA genome193. Other trans-splicers create specific cytotoxins194 in 
response to mRNA presence or cause cell death upon viral infection195. They have also 
been used to target cancer-linked mRNAs16, and can be delivered using viral vectors196. 
Furthermore, they can be combined with aptamers, resulting in small-molecule 
activated trans-splicers197.  
Genome engineering 
CRISPR/Cas9 nuclease allows programmable genome editing by effecting 
RNA-guided double strand break at a precise target site that is later repaired by 
homologous recombination (HR) or non-homologous end joining (NHEJ) introducing 
recombinant DNA at the cut site122. However, target recognition by the small 17-20 nt 
gRNA often results in many off targets, particularly in large genomes198,199. This has 
promoted the development of many methodologies to deal with the undesirable off-
targets. Cas9n, a nickase mutant that can only nick a single strand of the target DNA, 
necessitates making two separate DNA nicks for HR, eliminating NHEJ mediated 
repair and reducing off-target effects200. Systems have been developed to regulate the 
active time of Cas9, inducible by small molecule or light, in order to reduce off-target 
effects201,202. A recent high-fidelity Cas9 mutant has reduced strength of binding to 
DNA that reduces off-target effects to undetectable levels in the human genome203. 
Other methods include using bioinformatics tools, like CasOT (Table 1)93, and 
computational models to predict off-target effects, and design sgRNAs to avoid 
them93,204. Due to its portability and precision programmability, the CRISPR/Cas9 
genome engineering method has found widespread use for generating mouse models of 
disease205, disrupting latent HIV206, and repairing defective genes207, among others. 
Future directions 
Our capacity for rational engineering of a biological system depends on our 
ability to predictably control the functions of its various components, and thereby its 
behavioral response. The idea of using RNA as the molecular programming language 
in which to rewrite cellular functions relies on two of its fundamental properties: 
versatility and structural predictability. Firstly, RNA is highly versatile and plays many 
roles inside the cell in its capacity as an informational as well as a catalytic molecule. 
In that sense, RNA can be viewed as a vital linchpin that holds many disparate processes 
together, presumably as a relic from the old RNA world. As RNA engineering can only 
be used to affect those functions in the cell that are carried out or regulated by it, either 
alone or in combination with protein effectors, this functional versatility allows for 
wider control to the RNA coder. Secondly, RNA is a highly programmable molecule 
whose intra- and inter-molecular interactions rely on simple base-pairing rules and can 
be readily predicted. Together with the fact that most RNA functions depend on its 
primary sequence or its secondary structure, this predictability allows an RNA coder to 
rewrite these functions de novo. 
The RNA properties of versatility and predictability are also closely related with 
the 'parts' and 'models' paradigms of synthetic biology. The standardized parts paradigm 
aims to characterize biological parts to determine their functional specifications and 
catalogue them. The versatility of RNA therefore results in large libraries of RNA parts 
that can be re-used in biological circuits where their functions are needed. While the 
parts paradigm improves programmability using RNA, it is effective only for modular 
and composable parts. When parts crosstalk or influence each other in unexpected 
ways, the utility of the parts paradigm gets limited. This is where the predictability of 
RNA interactions can be very useful. In the 'models' paradigm of synthetic biology, the 
functional specifications of an RNA part can be predicted from its sequence using a 
computational model that can determine the sequence-structure-function relationship 
of the part. This expands the design space for RNA circuits by allowing the coder to 
design novel and orthogonal parts that do not crosstalk with each other. The ability to 
predict RNA behavior de novo is closely linked to the strengths of the computational 
model used. For the models paradigm to be effective, models need to capture not only 
the core features responsible for part function, but also the effect of the surrounding 
sequences on part behavior. Overall, RNA synthetic biology will benefit by a judicious 
use of parts and models for building biological systems. 
With considerable expansion in the number and type of RNA parts and models 
in the past few years, as well as their improved dynamic ranges, we have reached the 
stage in biological engineering where RNA programmability is already being leveraged 
for complex biological design.  The development of RNA devices capable of converting 
one form of signal to another31,135, and those able to emit RNA in response to a trigger 
(like light, a small molecule, or another RNA) could standardize the use of sRNAs as 
signal mediators in gene circuits37,47,88,133. Such RNA-only circuits driven by broad 
host-range viral promoters could be transplanted across species by only replacing the 
interface with the host gene expression135. However, many further steps are necessary 
for achieving RNA precision control over design-to-specification for biological 
systems for more predictable engineering. 
In order to achieve effective interfacing between different RNA parts, it is 
important that their input-output dynamic ranges match with each other208. While this 
is not likely to be a problem for parts with higher output dynamic range, it will severely 
jeopardize inter-connectivity for ribosensors of nanomolar ligand concentrations for 
example41. As connectors between incompatible RNA parts, libraries of signal 
amplifiers and converters need to be constructed31,135,209. Predictive models for RNA-
based regulation of translation or riboswitches need to be developed for eukaryotes, 
which will further expand RNA application. Furthermore, design methodologies for 
RNA parts design need to be automatable and scalable such that more orthogonal parts 
can be generated on demand37. To anticipate potential bugs and avoid paths to failure, 
parts must be characterized at least an order of magnitude above and below their normal 
range of operation, and their metabolic load and quantitative expression must be 
monitored in vivo52,210. 
As the use of the popular CRISPR/Cas9 technologies is expanded to larger 
circuits and genomes, it will be important to build accurate genome-wide models for 
predicting targeting and off-targeting efficiencies to reduce cross-talk effects of mis-
targeting211. To expand Cas9 specificity and functionality, it will also be important to 
continue the search for Cas9 homologs that use longer recognition sequences and have 
less stringent PAM sequence requirements. 
An important theoretical assumption that underlies almost all computational 
models describing sequence-structure-function relationships in RNA synthetic biology 
is that of thermodynamic equilibrium of RNA secondary structures22,37,39,41,42,106,107. 
While this may be a reasonable assumption for some applications, many RNA 
processes such as riboswitch activation41,75 and ribozyme folding212,213 are co-
transcriptional and their accurate modelling requires incorporation of RNA folding 
kinetics100,101. Similarly, accurately designing switching dynamics for inducible 
systems will require dynamic modelling of these systems214. As larger RNA-only or 
RNA-protein genetic circuits are rationally designed125,135, it will also be important to 
have an accurate characterization of their model parameters. For these purposes, in vitro 
transcription-translation systems will be a useful resource88. 
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